Connect to other sites within the UBM Medica Network
FDA Approves New Anti-Obesity Drug
Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.
Good Culinary News for Statin-Intolerant Patients
The real impact of nutritious menu changes at fast food chains like McDonalds remains to be seen, but these—along with modifying the dosage schedules of patients who appear to be statin-intolerant—may prove to have long-term salubrious effects.
The VitDISH Study: Vit D Supplementation Does Not Improve ISH in Older Patients
Vitamin D supplementation in the VitDISH study did not improve isolated systolic hypertension in elderly patients who were deficient.
Smoking and HDL: Bad News for the Good Lipid
Smoking can increase cholesterol, triglycerides, and LDL while decreasing HDL.
Diabetes Intervention Trims Weight, Not Cardiovascular Events
Although this study did not show benefits for heart disease, it has shown that weight loss improves many other health problems.
Go For The Glory Quiz: Foreign Body Aspiration; Persistent Snoring; Daily Dark Chocolate; Suspicious Pigmented Macule; Diabetic Ketoacidosis
Test your clinical skills in this week’s 5-question quiz.
Cardiovascular Complications of T2DM: Drugs to Watch
Colesevelam helps reduce serum glucose levels and also lowers LDL-C in patients with type 2 diabetes. Bromocriptine reduces the relative risk of cardiovascular events in patients with type 2 diabetes.
By clicking Accept, you agree to become a member of the UBM Medica Community.